Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How does sapropterin dosage change with comorbidities?

See the DrugPatentWatch profile for sapropterin

Standard Sapropterin Dosage

Sapropterin (Kuvan) treats phenylketonuria (PKU) in patients responsive to the drug. Initial dose is 10 mg/kg body weight once daily, taken with a PKU medical food and low-phenylalanine diet. After titration (up to 20 mg/kg/day), the effective dose is maintained long-term.[1]

Dosage Adjustments for Renal Impairment

Mild to moderate renal impairment (CrCl 30-89 mL/min) requires no change. For severe impairment (CrCl <30 mL/min) or end-stage renal disease, use is not recommended due to limited data and potential reduced clearance.[1][2]

Dosage Adjustments for Hepatic Impairment

Mild hepatic impairment (Child-Pugh A) needs no adjustment. Moderate (Child-Pugh B) limits dose to 10 mg/kg/day maximum. Severe (Child-Pugh C) contraindicates use, as sapropterin exposure increases significantly (up to 5-fold AUC rise).[1][2]

Impact of PKU Severity or Age-Related Comorbidities

No specific adjustments for PKU severity, but response testing (blood Phe levels after 2-4 weeks) guides continuation or discontinuation. Pediatrics (≥4 years): same 10-20 mg/kg range. Adults: weight-based dosing applies, with no upper age cap but monitoring for reduced efficacy in older patients.[1]

Drug Interactions Affecting Dosage

Strong CYP3A inhibitors (e.g., ketoconazole) increase sapropterin levels by 36-106%; reduce dose or monitor Phe levels. No routine adjustments for other common comorbidities like hypertension or diabetes unless involving these inhibitors.[2]

Sources
[1] Kuvan (sapropterin) Prescribing Information
[2] Drugs.com - Sapropterin Dosage Guide



Other Questions About Sapropterin :

What role do biomarkers play in monitoring sapropterin's effectiveness? How does sapropterin interact with pah diagnosis? How does body weight affect sapropterin dosing? What role do biomarkers play in monitoring sapropterin's effectiveness? How does sapropterin contribute to specific coenzyme synthesis? How was sapropterin's role in the body identified? What specific patient groups were clinically tested with sapropterin?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy